Literature DB >> 6603367

In vitro correction of the interleukin 2 defect of autoimmune mice.

T J Santoro, T A Luger, E S Ravache, J S Smolen, J J Oppenheim, A D Steinberg.   

Abstract

The effect of concanavalin A (Con A) and/or phorbol myristate acetate (PMA) on interleukin 2 (IL 2) production and tritiated thymidine incorporation was measured in young (6 weeks) and old (16-24 weeks) autoimmune mice by pulsing 5 X 10(6) unfractionated spleen cells with 5 micrograms of Con A and/or 5 ng of PMA for variable periods of time. The apparent deficiency in Con A-stimulated IL 2 production manifested by mice prone to the development of autoimmune disease was repaired by the addition of PMA. PMA did not enhance interleukin 1 (IL 1) secretion in autoimmune MRL-lpr mice either alone or in combination with Con A. The addition of purified IL 1 to Con A-pulsed autoimmune cells did not increase IL 2 production. Freeze-thaw experiments suggested that PMA does not promote IL 2 synthesis. Con A-pulsed cells plus PMA-pulsed cells do not syngergize. These data indicate that autoimmune-prone mice are capable of producing IL 2 and of proliferating in response to Con A provided the comitogen PMA is present. It can be argued that the failure to produce IL 2 or to respond to proliferative signals is not fundamental to the development of the disease sustained by autoimmune-prone mice.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603367     DOI: 10.1002/eji.1830130717

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

1.  Synergistic induction by calcium ionophore and phorbol ester of interleukin-2 (IL-2) receptor expression, IL-2 production, and proliferation in autoimmune MRL/MP-lpr mice.

Authors:  T Koizumi; Y Nakao; T Matsui; Y Katakami; T Nakagawa; T Fujita
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

2.  Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis.

Authors:  C F Moyer; J D Strandberg; C L Reinisch
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

3.  Delineation of two defects responsible for T-cell hyporesponsiveness to concanavalin A in MRL congenic mice.

Authors:  R Cameron; J D Waterfield
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

4.  T-cell antigen-receptor genes in autoimmune mice.

Authors:  Y Hashimoto; A M Maxam; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  A new T cell subset expressing B220 and CD4 in lpr mice: defects in the response to mitogens and in the production of IL-2.

Authors:  T Asano; S Tomooka; B A Serushago; K Himeno; K Nomoto
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

6.  Reversible interleukin-2 response defects in systemic lupus erythematosus.

Authors:  R J Warrington; P J Sauder; J Homik; W Ofosu-Appiah
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

Review 7.  Differential gene expression in autoimmune mice.

Authors:  J D Mountz; J F Mushinski; A D Steinberg
Journal:  Surv Immunol Res       Date:  1985

Review 8.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

9.  Interleukin-2 production in Brown-Norway rats with HgCl2-induced autoimmune disease: paradoxical in vivo versus in vitro findings.

Authors:  D Baran; O Lantz; P Dosquet; A Sfaksi; P Druet
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

10.  Ability of isoprinosine to restore interleukin-2 production and T cell proliferation in autoimmune mice.

Authors:  M Fischbach; N Talal
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.